Flow cytometric characterization of cell surface markers to differentiate between fibroblasts and mesenchymal stem cells of different origin
Open Access
- 5 April 2021
- journal article
- research article
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 19 (5) , 1487-1496
Abstract
Introduction: Identification and purification of mesenchymal stem cells (MSCs) expanded in culture for therapeutic use is crucial for improved yield and optimal results. Fibroblasts are the most common cell type in connective tissue and are commonly found as contaminants of MSC cultures, affecting cell yield and potentially causing tumour formation after cell transplantation. In the current study, we wished to identify cell surface markers that can differentiate MSCs of different origins from fibroblasts.Material and methods: Mesenchymal stem cells were isolated from bone marrow, adipose tissue, Wharton’s jelly, and placental tissue, and fibroblasts were isolated from foreskin (as a negative control) in order to examine the differences in the expression of a panel of 14 different cell surface markers using multiplex flow cytometry.Results: Our results indicate that the following markers could be useful in differentiating between fibroblasts and MSCs derived from the following: adipose tissue – CD79a, CD105, CD106, CD146, and CD271; Wharton’s jelly – CD14, CD56, and CD105; bone marrow – CD105, CD106, and CD146; and placental tissue – CD14, CD105, and CD146. Furthermore, we found that, contradictory to previous studies, CD26 is not fibroblast specific.Conclusions: The results of our study indicate that cell surface markers may prove to be a useful tool in the discrimination between MSCs of different origins and fibroblasts, and thus may be used to authenticate the identity of the isolated cells.Keywords
This publication has 30 references indexed in Scilit:
- CD106 Identifies a Subpopulation of Mesenchymal Stem Cells with Unique Immunomodulatory PropertiesPLOS ONE, 2013
- CD26‐mediated co‐stimulation in human CD8+T cells provokes effector function via pro‐inflammatory cytokine productionImmunology, 2013
- Sources of Adult Mesenchymal Stem Cells Applicable for Musculoskeletal Applications - A Systematic Review of the LiteratureThe Open Orthopaedics Journal, 2011
- The CD271 expression could be alone for establisher phenotypic marker in Bone Marrow derived mesenchymal stem cells.Folia Histochemica et Cytobiologica, 2011
- Fibroblasts share mesenchymal phenotypes with stem cells, but lack their differentiation and colony-forming potentialBiology of the Cell, 2011
- Markers Distinguishing Mesenchymal Stem Cells from Fibroblasts Are Downregulated with PassagingStem Cells and Development, 2011
- Bone marrow‐derived mesenchymal stem cells express the pericyte marker 3G5 in culture and show enhanced chondrogenesis in hypoxic conditionsJournal of Orthopaedic Research, 2010
- Multilineage differentiation potential of human dermal skin‐derived fibroblastsExperimental Dermatology, 2008
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statementCytotherapy, 2005